Autifony Therapeutics
Latest round
- Series A
Last raised
- Jun 2015
Total raised
- $13M
Investors
- 5
About Autifony Therapeutics
Based in Hertfordshire, UK, and founded in 2011 by CEO Charles H. Large, and CRO Charles H.a. Autifony Therapeutics is a clinical-stage biotechnology company that focuses on developing medicines to address rare genetic CNS disorders through its ion channel drug discovery platform. In March 2017, Autifony Therapeutics Ltd. The company's primary product pipeline consists of clinical-stage, small-molecule modulators targeting the Kv3 family of potassium channels. These modulators are expected to demonstrate efficacy in treating Fragile X syndrome and rare myoclonic epilepsy syndromes. Additionally, Autifony has preclinical programs utilizing novel Kv3 modulators with potential applications in various CNS disorders, such as schizophrenia and hearing loss.
Who invested in Autifony Therapeutics
5 investors across 1 round
See all investors in Autifony Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 16, 2015
Amount
$13M
Investors
Questions about Autifony Therapeutics
Who invested in Autifony Therapeutics?
Autifony Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Autifony Therapeutics raised?
Autifony Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Autifony Therapeutics last raise money?
Autifony Therapeutics's most recent round on record is a Series A, in Jun 2015.
What does Autifony Therapeutics do?
Based in Hertfordshire, UK, and founded in 2011 by CEO Charles H.
Where is Autifony Therapeutics headquartered?
Autifony Therapeutics is headquartered in UK.
Which VCs invest in companies like Autifony Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Autifony Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Autifony Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.